Indian Journal of Nephrology Home 

ORIGINAL ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2020  |  Volume : 30  |  Issue : 2  |  Page : 77--84

Link between ACE I/D gene polymorphism and dyslipidemia in diabetic nephropathy: A case-control study from Hyderabad, India

Umme Najiya Mahwish1, Kamakshi Chaithri Ponnaluri1, Babi Heera2, Satish Reddy Alavala3, K Rudrama Devi4, Sree Bhushan Raju3, G Suman Latha1, Parveen Jahan2 
1 Department of Genetics, Osmania University, Hyderabad, Telangana, India
2 Department of Zoology, Maulana Azad National Urdu University, Hyderabad, Telangana, India
3 Department of Nephrology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India
4 Department of Zoology, Osmania University, Hyderabad, Telangana, India

Correspondence Address:
Parveen Jahan
Department of Zoology, Maulana Azad National Urdu University, Hyderabad - 500 032, Telangana
India

Introduction: Diabetic nephropathy (DN) is the commonest single cause of end-stage renal failure, and dyslipidemia is a critical risk factor in the occurrence of DN. In the light of recent reports emphasizing the importance of angiotensin I-converting enzyme (ACE) in the modulation of plasma lipids, we sought to evaluate the influence of ACE I/D gene polymorphism with dyslipidemia status among type 2 diabetic (T2D) patients with and without nephropathy in the genetic predisposition and the progression to DN. Method: This study comprised of 600 subjects, which include patients with DN, T2D, and healthy controls (HC). Polymerase chain reaction based genotyping of ACE I/D polymorphism was performed and appropriate statistical analysis was done.Results: Out of the 600 subjects, 20 (10%) of the HC, 73 (36.5%) of the T2D group, and 125 (62.5%) of the DN subjects had dyslipidemia. The D allele (0.62) and DD (42.5) genotype frequencies were higher in the DN group in comparison with T2D and HC (P < 0.05). The genotypes also varied among patients with dyslipidemia (χ2 5.04; P < 0.05) but not in the non-dyslipidemia group. Under the co-dominant model, DD genotype conferred a risk of 1.26 (P < 0.001) toward DN, whereas the ID genotype offered protection from DN among the dyslipidemic subjects (OR = 0.05; P < 0.01). In addition, genotype-dependent difference was seen in the plasma lipid levels among study groups. A multiple logistic regression analysis revealed male gender, BMI, HbA1c, TG, HDL, and ACE DD genotype as independent risk factors for the development of DN. Conclusion: The study showed a significant predisposing association of ACE DD genotype with DN and protective effect of ID genotype on DN in the dyslipidemia subgroup.

How to cite this article:
Mahwish UN, Ponnaluri KC, Heera B, Alavala SR, Devi K R, Raju SB, Latha G S, Jahan P. Link between ACE I/D gene polymorphism and dyslipidemia in diabetic nephropathy: A case-control study from Hyderabad, India.Indian J Nephrol 2020;30:77-84

How to cite this URL:
Mahwish UN, Ponnaluri KC, Heera B, Alavala SR, Devi K R, Raju SB, Latha G S, Jahan P. Link between ACE I/D gene polymorphism and dyslipidemia in diabetic nephropathy: A case-control study from Hyderabad, India. Indian J Nephrol [serial online] 2020 [cited 2020 Jul 4 ];30:77-84
Available from: http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2020;volume=30;issue=2;spage=77;epage=84;aulast=Mahwish;type=0